This inventor holds 22 USPTO granted patents and 7 published patent applications and 15 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: China Mobile Communications Group Co., Ltd., Chinese Academy of Sciences, China Mobile Communications Corporation. Active years: 2011-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Jilin, CN (2017 - 2018)
- Beijing, CN (2011 - 2022)
Company Filing History:
7 out of 135 
5 out of 3,364 
4 out of 118 
Years Active: 2011-2026
Areas of Expertise:
Title: Inventor Jing Jin: Pioneering Innovations in Pharmaceutical and Communication Technologies
Introduction: Jing Jin is a prominent inventor based in Beijing, China, known for his significant contributions to the fields of pharmaceuticals and communication technologies. With a remarkable portfolio of 19 patents, he has made strides in developing innovative solutions aimed at addressing critical health issues and enhancing communication systems.
Latest Patents: Among his latest inventions is a patent titled "Benzamide compound and preparation method, use, and pharmaceutical composition thereof." This invention relates to a benzamide compound, represented by a specific formula, which acts as a STAT3 inhibitor. It holds potential for preventing and/or treating various diseases linked to STAT3 activity, including tumors, autoimmune diseases, renal diseases, cardiovascular diseases, inflammation, metabolic/endocrine dysfunctions, and neurological diseases. Another notable patent from Jing Jin is a "Transmission method and device," which presents a novel method for managing time-frequency resources in communication networks, facilitating efficient data transmission among nodes.
Career Highlights: Jing Jin has collaborated with leading telecommunications companies, notably China Mobile Communications Group Co., Ltd. and China Mobile Communications Corporation. His experiences in these organizations have equipped him with valuable insights and expertise, contributing to his innovative endeavors.
Collaborations: Throughout his career, Jing Jin has worked alongside esteemed colleagues, including Qixing Wang and Hui Tong. Collaborating with such talented individuals has further enhanced his ability to innovate and drive advancements in technology and pharmaceuticals.
Conclusion: Jing Jin's remarkable journey as an inventor showcases his dedication to innovation and his ability to tackle complex challenges through his patented inventions. His work in developing solutions for health-related issues and enhancing communication techniques underscores the significant impact he has made in his fields of expertise. As he continues to explore new frontiers, Jing Jin remains a key figure in the ongoing quest for innovation in pharmaceuticals and communication technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile